AGNELLI, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 14.857
EU - Europa 10.740
AS - Asia 8.850
SA - Sud America 1.742
AF - Africa 167
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 10
Totale 36.383
Nazione #
US - Stati Uniti d'America 14.586
SG - Singapore 4.367
UA - Ucraina 2.191
IE - Irlanda 2.151
IT - Italia 1.501
BR - Brasile 1.492
RU - Federazione Russa 1.342
HK - Hong Kong 1.240
CN - Cina 1.200
VN - Vietnam 1.072
SE - Svezia 960
DE - Germania 822
FI - Finlandia 674
GB - Regno Unito 353
KR - Corea 286
TR - Turchia 191
FR - Francia 172
CA - Canada 145
IN - India 103
AT - Austria 100
PL - Polonia 92
MX - Messico 88
AR - Argentina 85
CH - Svizzera 77
BD - Bangladesh 64
NL - Olanda 64
ZA - Sudafrica 58
BE - Belgio 52
UZ - Uzbekistan 50
EC - Ecuador 46
JP - Giappone 42
IQ - Iraq 40
LB - Libano 35
CZ - Repubblica Ceca 33
LT - Lituania 33
ES - Italia 32
CL - Cile 29
GR - Grecia 27
PK - Pakistan 27
VE - Venezuela 25
EG - Egitto 23
ID - Indonesia 23
CO - Colombia 22
MA - Marocco 18
KE - Kenya 15
PY - Paraguay 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
JO - Giordania 12
PE - Perù 12
SA - Arabia Saudita 12
EU - Europa 10
KG - Kirghizistan 10
RO - Romania 10
SK - Slovacchia (Repubblica Slovacca) 10
AZ - Azerbaigian 8
BG - Bulgaria 8
UY - Uruguay 8
CR - Costa Rica 7
DZ - Algeria 7
IL - Israele 7
BO - Bolivia 6
EE - Estonia 6
HR - Croazia 6
JM - Giamaica 6
NZ - Nuova Zelanda 6
OM - Oman 6
PA - Panama 6
TH - Thailandia 6
CI - Costa d'Avorio 5
NG - Nigeria 5
PS - Palestinian Territory 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
DK - Danimarca 4
KZ - Kazakistan 4
NP - Nepal 4
GT - Guatemala 3
GY - Guiana 3
PH - Filippine 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BN - Brunei Darussalam 2
BW - Botswana 2
BZ - Belize 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
KW - Kuwait 2
LY - Libia 2
ME - Montenegro 2
MW - Malawi 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
SD - Sudan 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 36.344
Città #
Singapore 2.766
Chandler 2.342
Dublin 2.141
Hong Kong 1.234
San Mateo 1.222
Jacksonville 1.134
Boardman 746
Dong Ket 681
Altamura 671
Santa Clara 647
Ashburn 630
Medford 581
Princeton 575
Lawrence 501
Des Moines 486
Moscow 450
Wilmington 396
Ann Arbor 383
Andover 360
Perugia 356
Seoul 284
Beijing 261
Los Angeles 220
Munich 219
Saint Petersburg 174
New York 156
Ho Chi Minh City 147
Izmir 144
São Paulo 141
Helsinki 135
Piscataway 123
Norwalk 112
Hanoi 95
San Paolo di Civitate 93
Shanghai 89
The Dalles 76
Redmond 66
Turku 66
Brooklyn 59
Dallas 58
Rome 56
Brussels 51
Nuremberg 51
Chicago 50
Rio de Janeiro 49
Warsaw 48
Montreal 45
Stockholm 45
Houston 43
Boston 40
Tokyo 39
Woodbridge 39
Atlanta 37
Columbus 37
Ottawa 37
Belo Horizonte 36
Falls Church 36
Dearborn 35
Denver 35
Frankfurt am Main 35
Johannesburg 34
Orem 33
Chennai 32
Hefei 32
London 31
Brasília 30
Redwood City 29
Seattle 29
Mexico City 28
San Francisco 28
Vienna 27
Phoenix 26
Den Haag 25
Amsterdam 24
Toronto 24
Guangzhou 23
Poplar 23
Ankara 21
Manchester 21
Auburn Hills 20
Falkenstein 20
Philadelphia 20
Charlotte 19
Mumbai 18
Amelia 16
Campinas 16
Fortaleza 16
Zhengzhou 16
Haiphong 15
Ribeirão Preto 15
Baghdad 14
Bexley 14
Hanover 14
Olomouc 14
Salvador 14
Secaucus 14
São José dos Campos 14
Brno 13
Council Bluffs 13
Curitiba 13
Totale 22.712
Nome #
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 125
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 123
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. 122
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 119
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 115
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 113
Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study 111
Epidemiology of cerebral vein and sinus thrombosis. 110
Acute stroke symptoms: Do differences exist between sexes? 110
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 107
Aspirin for preventing the recurrence of venous thromboembolism. 107
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 106
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 105
Secondary stroke prevention in women. 105
[Spinal anesthesia and prophylaxis of venous thromboembolism. Results of a national survey]. 103
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 103
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 100
Early admission to stroke unit influences clinical outcome 99
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. 99
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 98
Risk factors for venous thromboembolism in the elderly: results of the master registry. 97
A prospective study on cardiovascular events after acute pulmonary embolism 96
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. 96
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 96
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter related deep vein thrombosis in a child with acute lymphoblastic leukemia 95
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 95
Severity of acute intracerebral haemorrhage, elderly age and atrial fibrillation: Independent predictors of poor outcome at three months 95
Isolated monoparesis following stroke 94
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 94
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 93
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 93
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 93
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 93
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 92
Gene-drug interaction in stroke. 92
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 92
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 92
Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions. 91
A sudden neurological deficit in a patient with endocarditis. 91
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 91
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome. 91
[Acute immunoallergic thrombopenia due to sulfamethoxazole-trimethoprim]. 91
[Effect of platelet-derived growth factor on the in vitro cell proliferation of chick embryo skin]. 91
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. 91
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 91
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 91
Prevention of venous thromboembolism in surgical patients 90
Initial treatment of venous thromboembolism 90
Arterite temporale occulta: contributo casistico e revisione della letteratura 90
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 90
Acute pulmonary embolism: risk stratification in the emergency department. 90
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. 90
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 90
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 90
Vascular cognitive impairment: a pragmatic concept 89
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 89
Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism 89
Acute pulmonary embolism. 89
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 89
Risk factors for adverse short-term outcome in patients with pulmonary embolism 88
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 88
Cancer-associated ischemic stroke: A retrospective multicentre cohort study 88
New pharmacologic strategies for arterial and venous thromboembolism 87
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 87
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 87
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery The @RISTOS Project 87
Activation of blood coagulation in patients undergoing postoperative blood salvage and reinfusion of unwashed whole blood after total knee arthroplasty 86
Risk factor for upper limb deep vein thrombosis 86
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 86
[Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. 86
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. 86
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. 86
Cardiac hemangioma of the right atrium: a possible cause of cerebellar stroke. 86
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 86
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 86
A new strategy for anticoagulation: The factor XI inhibitors 85
Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. 85
Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. 85
Venous thromboembolism and atherosclerosis: common denominators or different diseases? 85
Acute pulmonary embolism: external validation of an integrated risk stratification model. 85
Fatal Nocardia farcinica Bacteremia Diagnosed by Matrix-Assisted Laser Desorption-Ionization Time of Flight Mass Spectrometry in a Patient with Myelodysplastic Syndrome Treated with Corticosteroids. 85
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 85
[Occult temporal arteritis. Case reports and review of the literature]. 85
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? 84
D-dimer for riskstratification in patients with acute pulmonary embolism. 84
The good use of plasma. A critical analysis of five international guidelines. 84
Aspirin for the prevention of recurrent venous thromboembolism the INSPIRE collaboration 84
Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events. 84
Clinical skills or high-tech MR in TIA patients: what makes the difference? 84
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 84
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 84
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 83
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 83
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing 83
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 83
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 83
Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery 82
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy 82
New anticoagulants 82
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS 82
Totale 9.243
Categoria #
all - tutte 186.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.012 0 0 0 0 0 141 249 36 424 96 334 732
2021/20224.446 53 780 64 153 232 31 46 1.540 68 167 469 843
2022/20238.339 663 1.638 121 542 651 1.170 21 340 2.832 23 264 74
2023/20242.458 205 309 189 40 47 22 475 123 164 119 427 338
2024/20256.653 52 714 151 240 924 326 179 510 1.438 429 1.052 638
2025/20267.309 1.217 868 729 1.822 1.870 803 0 0 0 0 0 0
Totale 37.398